Monthly Archives: November 2015

Cyteir Therapeutics Announces Study Showing RAD51 Modulators Protect Diabetic Mice from Type 1 Diabetes (T1D)

2018-02-11T00:45:58+00:00

Cyteir Therapeutics Announces Study Showing RAD51 Modulators Protect Diabetic Mice from Type 1 Diabetes (T1D)  --Data demonstrates that therapeutic targeting of the AID/RAD51 axis in B cells may block development of T1D by converting B cells to a suppressive population capable of inhibiting disease development --  --First demonstration of synthetic lethal pairs in a [...]

Cyteir Therapeutics Announces Study Showing RAD51 Modulators Protect Diabetic Mice from Type 1 Diabetes (T1D) 2018-02-11T00:45:58+00:00

Jackson Laboratory Spinout Cyteir Therapeutics Inc. Announces $5.5 Million Series A Financing and Appointment of Donald F. Corcoran as President and Chief Executive Officer

2018-02-09T23:41:03+00:00

Jackson Laboratory Spinout Cyteir Therapeutics Inc. Announces $5.5 Million Series A Financing and Appointment of Donald F. Corcoran as President and Chief Executive Officer  Proceeds will provide funding to Cyteir Therapeutics to advance its genomic instability and DNA repair programs  Cambridge, Mass., and Bar Harbor, Maine – November 5, 2015 – Cyteir Therapeutics, a [...]

Jackson Laboratory Spinout Cyteir Therapeutics Inc. Announces $5.5 Million Series A Financing and Appointment of Donald F. Corcoran as President and Chief Executive Officer 2018-02-09T23:41:03+00:00